National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Taltz® is indicated for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.

Rapid Review

Commenced Completed Outcome
28/06/2016 26/07/2016 Full Pharmacoeconomic Evaluation Recommended at the Submitted Price

September 2016

The HSE has approved reimbursement following confidential price negotiations.